表紙:プロバイオティクス市場:成分別、機能別、用途別、エンドユーザー別:世界の機会分析と業界予測(2021年~2030年)
市場調査レポート
商品コード
1043747

プロバイオティクス市場:成分別、機能別、用途別、エンドユーザー別:世界の機会分析と業界予測(2021年~2030年)

Probiotics Market by Ingredient, Function, Application, and End User : Global Opportunity Analysis and Industry Forecast 2021-2030

出版日: | 発行: Allied Market Research | ページ情報: 英文 302 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.61円
プロバイオティクス市場:成分別、機能別、用途別、エンドユーザー別:世界の機会分析と業界予測(2021年~2030年)
出版日: 2021年10月14日
発行: Allied Market Research
ページ情報: 英文 302 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のプロバイオティクスの市場規模は、2020年に341億米ドルとなりました。

同市場は今後8.6%のCAGRで拡大し、2030年には739億米ドルに達すると予測されています。

プロバイオティクスは、十分な量を摂取することで、腸内環境の改善や腸の炎症の減少など、人体に有益な効果をもたらします。プロバイオティクスは、病気を未然に防ぐ免疫システムを強化するため、予防医療に重要な役割を果たします。そのため、予防医療に対する意識の高まりが、市場全体の成長に寄与すると考えられます。

栄養補助食品、特に乳児用ミルクへのプロバイオティクスの使用に関する規制は、一部の地域では非常に厳しく、市場関係者にとっての課題となることが予想されます。

当レポートでは、世界のプロバイオティクス市場について調査し、市場の概要とともに、成分別、機能別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 市場シェア分析/主要参入企業のポジショニング、2020年
  • 主な影響要因
    • 健康への懸念の高まり
    • 消費者の意識の低さ
    • 研究開発への投資拡大
    • 厳しい政府規制
    • 機能性食品の消費増加
  • 市場力学
    • 促進要因
      • 健康への懸念の高まり
      • 機能性食品の消費増加
      • 研究開発への投資拡大
    • 抑制要因
      • 政府の規制
      • プロバイオティクス製品の有効性に関する消費者の意識レベルが低い
    • 市場の機会
      • 発展途上国におけるプロバイオティクス製品の需要の高まり
      • プロバイオティクスの利点についての意識を高める
  • COVID-19の影響
  • バリューチェーン分析

第4章 プロバイオティクス市場:成分別

  • 概要
    • 市場規模と予測
  • バクテリア
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 酵母
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測

第5章 プロバイオティクス市場:機能別

  • 概要
    • 市場規模と予測
  • 通常
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 予防ヘルスケア
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 治療
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測

第6章 プロバイオティクス市場:用途別

  • 概要
    • 市場規模と予測
  • 食品・飲料
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 栄養補助食品
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 動物飼料
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測

第7章 プロバイオティクス市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 人間
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測
  • 動物
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測

第8章 プロバイオティクス市場:地域別

  • 概要
    • 市場規模と予測
  • 北米
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:成分別
    • 市場規模と予測:機能別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:成分別
    • 市場規模と予測:機能別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • 英国
      • フランス
      • オランダ
      • ドイツ
      • トルコ
      • その他
  • アジア太平洋
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:成分別
    • 市場規模と予測:機能別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • 中国
      • 日本
      • インド
      • 韓国
      • オーストラリア
      • その他
  • ラテンアメリカ、中東、アフリカ
    • 概要
    • 主要な市場動向、成長要因、および機会
    • 市場規模と予測:成分別
    • 市場規模と予測:機能別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • ブラジル
      • 南アフリカ
      • アラブ首長国連邦
      • その他

第9章 競合情勢

  • 主な成功戦略
  • 製品マッピング
  • 競争力ダッシュボード
  • 競争力ヒートマップ
  • 主な発展
    • 買収
    • 事業拡大
    • 製品発売

第10章 企業プロファイル

  • Archer-Daniels-Midland Company
  • BioGaia AB
  • Chr. Hansen Holding A/S
  • Danone
  • Deerland Probiotics & Enzymes Inc.
  • Lallemand Inc.
  • Nestle S.A
  • Probi AB
  • Probiotical S.P.A.
  • Yakult Honsha Co. Ltd
図表

LIST OF TABLES

  • TABLE 01.GLOBAL PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 02.PROBIOTICS MARKET REVENUE FOR BACTERIA, BY REGION, 2020-2030 ($BILLION)
  • TABLE 03.PROBIOTICS MARKET REVENUE FOR YEAST, BY REGION, 2020-2030 ($BILLION)
  • TABLE 04.GLOBAL PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 05.PROBIOTICS MARKET REVENUE FOR REGULAR, BY REGION, 2020-2030 ($BILLION)
  • TABLE 06.PROBIOTICS MARKET REVENUE FOR PREVENTATIVE HEALTHCARE, BY REGION, 2020-2030 ($BILLION)
  • TABLE 07.PROBIOTICS MARKET REVENUE FOR THERAPEUTIC, BY REGION, 2020-2030 ($BILLION)
  • TABLE 08.GLOBAL PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 09.PROBIOTICS MARKET REVENUE FOR FOOD & BEVERAGE, BY REGION, 2020-2030 ($BILLION)
  • TABLE 10.PROBIOTICS MARKET REVENUE FOR DIETARY SUPPLEMENTS, BY REGION, 2020-2030 ($BILLION)
  • TABLE 11.PROBIOTICS MARKET REVENUE FOR ANIMAL FEED, BY REGION, 2020-2030 ($BILLION)
  • TABLE 12.PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 13.PROBIOTICS MARKET REVENUE FOR HUMAN, BY REGION, 2020-2030 ($BILLION)
  • TABLE 14.PROBIOTICS MARKET REVENUE FOR ANIMAL, BY REGION, 2020-2030 ($BILLION)
  • TABLE 15.PROBIOTICS MARKET, BY REGION, 2020-2030 ($BILLION)
  • TABLE 16.NORTH AMERICA PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 17.NORTH AMERICA PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 18.NORTH AMERICA PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 19.NORTH AMERICA PROBIOTICS MARKET, BY END USER, 2020-2030 ($BILLION)
  • TABLE 20.NORTH AMERICA PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
  • TABLE 21.U.S. PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 22.U.S. PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 23.U.S. PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 24.U.S. PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 25.CANADA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 26.CANADA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 27.CANADA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 28.CANADA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 29.MEXICO PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 30.MEXICO PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 31.MEXICO PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 32.MEXICO PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 33.EUROPE PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 34.EUROPE PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 35.EUROPE PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 36.EUROPE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 37.EUROPE PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
  • TABLE 38.UK PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 39.UK PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 40.UK PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 41.UK PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 42.FRANCE PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 43.FRANCE PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 44.FRANCE PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 45.FRANCE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 46.THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 47.THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 48.THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 49.THE NETHERLANDS PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 50.GERMANY PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 51.GERMANY PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 52.GERMANY PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 53.GERMANY PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 54.TURKEY PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 55.TURKEY PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 56.TURKEY PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 57.TURKEY PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 58.REST OF EUROPE PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 59.REST OF EUROPE PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 60.REST OF EUROPE PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 61.REST OF EUROPE PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 62.ASIA-PACIFIC PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 63.ASIA-PACIFIC PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 64.ASIA-PACIFIC PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 65.ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 66.ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
  • TABLE 67.CHINA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 68.CHINA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 69.CHINA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 70.CHINA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 71.JAPAN PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 72.JAPAN PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 73.JAPAN PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 74.JAPAN PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 75.INDIA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 76.INDIA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 77.INDIA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 78.INDIA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 79.SOUTH KOREA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 80.SOUTH KOREA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 81.SOUTH KOREA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 82.SOUTH KOREA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 83.AUSTRALIA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 84.AUSTRALIA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 85.AUSTRALIA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 86.AUSTRALIA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 87.REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 88.REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 89.REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 90.REST OF ASIA-PACIFIC PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 91.LAMEA PROBIOTICS MARKET, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 92.LAMEA PROBIOTICS MARKET, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 93.LAMEA PROBIOTICS MARKET, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 94.LAMEA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 95.LAMEA PROBIOTICS MARKET REVENUE, BY COUNTRY, 2020-2030 ($BILLION)
  • TABLE 96.BRAZIL PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 97.BRAZIL PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 98.BRAZIL PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 99.BRAZIL PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 100.SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 101.SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 102.SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 103.SOUTH AFRICA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 104.UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 105.UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 106.UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 107.UNITED ARAB EMIRATES PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 108.REST OF LAMEA PROBIOTICS MARKET REVENUE, BY INGREDIENTS, 2020-2030 ($BILLION)
  • TABLE 109.REST OF LAMEA PROBIOTICS MARKET REVENUE, BY FUNCTION, 2020-2030 ($BILLION)
  • TABLE 110.REST OF LAMEA PROBIOTICS MARKET REVENUE, BY APPLICATION, 2020-2030 ($BILLION)
  • TABLE 111.REST OF LAMEA PROBIOTICS MARKET REVENUE, BY END USER, 2020-2030 ($BILLION)
  • TABLE 112.ARCHER-DANIELS-MIDLAND COMPANY: KEY EXECUTIVES
  • TABLE 113.ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT
  • TABLE 114.ARCHER-DANIELS-MIDLAND COMPANY: OPERATING SEGMENTS
  • TABLE 115.ARCHER-DANIELS-MIDLAND COMPANY: PRODUCT PORTFOLIO
  • TABLE 116.ARCHER-DANIELS-MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 117.ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
  • TABLE 118.BIOGAIA AB: KEY EXECUTIVES
  • TABLE 119.BIOGAIA AB: COMPANY SNAPSHOT
  • TABLE 120.BIOGAIA AB: OPERATING SEGMENTS
  • TABLE 121.BIOGAIA AB: PRODUCT PORTFOLIO
  • TABLE 122.BIOGAIA AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 123.BIOGAIA AB: NET SALES, 2018-2020 ($MILLION)
  • TABLE 124.CHR. HANSEN HOLDING A/S: KEY EXECUTIVES
  • TABLE 125.CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT
  • TABLE 126.CHR. HANSEN HOLDING A/S: OPERATING SEGMENTS
  • TABLE 127.CHR. HANSEN HOLDING A/S: PRODUCT PORTFOLIO
  • TABLE 128.CHR. HANSEN HOLDING A/S: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 129.CHR. HANSEN HOLDING A/S: NET SALES, 2018-2020 ($MILLION)
  • TABLE 130.DANONE: KEY EXECUTIVES
  • TABLE 131.DANONE: COMPANY SNAPSHOT
  • TABLE 132.DANONE: PRODUCT PORTFOLIO
  • TABLE 133.DANONE: NET SALES, 2018-2020 ($MILLION)
  • TABLE 134.DEERLAND PROBIOTICS & ENZYMES INC.: KEY EXECUTIVES
  • TABLE 135.DEERLAND PROBIOTICS & ENZYMES INC.: COMPANY SNAPSHOT
  • TABLE 136.DEERLAND PROBIOTICS & ENZYMES INC.: PRODUCT PORTFOLIO
  • TABLE 137.LALLEMAND INC.: KEY EXECUTIVES
  • TABLE 138.LALLEMAND INC.: COMPANY SNAPSHOT
  • TABLE 139.LALLEMAND INC.: PRODUCT PORTFOLIO
  • TABLE 140.NESTLE S.A.: KEY EXECUTIVES
  • TABLE 141.NESTLE S.A.: COMPANY SNAPSHOT
  • TABLE 142.NESTLE S.A.: OPERATING SEGMENTS
  • TABLE 143.NESTLE S.A.: PRODUCT PORTFOLIO
  • TABLE 144.NESTLE S.A.: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 145.NESTLE S.A.: NET SALES, 2018-2020 ($MILLION)
  • TABLE 146.PROBI AB: KEY EXECUTIVES
  • TABLE 147.PROBI AB: COMPANY SNAPSHOT
  • TABLE 148.PROBI AB: OPERATING SEGMENTS
  • TABLE 149.PROBI AB: PRODUCT PORTFOLIO
  • TABLE 150.PROBI AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 151.PROBI AB: NET SALES, 2018-2020 ($MILLION)
  • TABLE 152.PROBIOTICAL S.P.A.: KEY EXECUTIVES
  • TABLE 153.PROBIOTICAL S.P.A.: COMPANY SNAPSHOT
  • TABLE 154.PROBIOTICAL S.P.A.: PRODUCT PORTFOLIO
  • TABLE 155.YAKULT HONSHA CO., LTD.: KEY EXECUTIVES
  • TABLE 156.YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
  • TABLE 157.YAKULT HONSHA CO., LTD.: OPERATING SEGMENTS
  • TABLE 158.YAKULT HONSHA CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 159.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • TABLE 160.YAKULT HONSHA CO., LTD.: NET SALES, 2018-2020 ($MILLION)

LIST OF FIGURES

  • FIGURE 01.KEY MARKET SEGMENT
  • FIGURE 02.GLOBAL PROBIOTICS MARKET SNAPSHOT, 2020-2030
  • FIGURE 03.TOP INVESTMENT POCKETS
  • FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06.MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 07.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 08.MODERATE INTENSITY OF RIVALRY
  • FIGURE 10.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2020
  • FIGURE 11.TOP IMPACTING FACTORS
  • FIGURE 12.PROBIOTICS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.PROBIOTICS MARKET, BY INGREDIENTS, 2020 (%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR BACTERIA, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR YEAST, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 17.PROBIOTICS MARKET, BY FUNCTION, 2020 (%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR REGULAR, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR PREVENTATIVE HEALTHCARE, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR THERAPEUTIC, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 21.PROBIOTICS MARKET, BY APPLICATION, 2020 (%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR FOOD & BEVERAGE, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR ANIMAL FEED, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 25.PROBIOTICS MARKET, BY END USER, 2020 (%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR HUMAN, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS MARKET REVENUE FOR ANIMAL, BY COUNTRY, 2020 & 2030 (%)
  • FIGURE 28.PROBIOTICS MARKET, BY REGION, 2020 (%)
  • FIGURE 29.U.S. PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 30.CANADA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 31.MEXICO PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 32.UK PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 33.FRANCE PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 34.THE NETHERLANDS PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 35.GERMANY PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 36.TURKEY PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 37.REST OF EUROPE PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 38.CHINA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 39.JAPAN PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 40.INDIA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 41.SOUTH KOREA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 42.AUSTRALIA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 43.REST OF ASIA-PACIFIC PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 44.BRAZIL PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 45.SOUTH AFRICA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 46.UNITED ARAB EMIRATES PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 47.REST OF LAMEA PROBIOTICS MARKET, 2020-2030 ($BILLION)
  • FIGURE 48.TOP WINNING STRATEGIES, BY YEAR, 2018-2020*
  • FIGURE 49.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2020* (%)
  • FIGURE 50.TOP WINNING STRATEGIES, BY COMPANY, 2018-2020*
  • FIGURE 51.PRODUCT MAPPING OF TOP 10 KEY PLAYERS
  • FIGURE 52.COMPETITIVE DASHBOARD OF TOP 10 KEY PLAYERS
  • FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 54.ARCHER-DANIELS-MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 55.ARCHER-DANIELS-MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 56.ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 57.ARCHER-DANIELS-MIDLAND COMPANY: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 58.BIOGAIA AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 59.BIOGAIA AB: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 60.BIOGAIA AB: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 61.BIOGAIA AB: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 62.CHR. HANSEN HOLDING A/S: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 63.CHR. HANSEN HOLDING A/S: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 64.CHR. HANSEN HOLDING A/S: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 65.CHR. HANSEN HOLDING A/S: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 66.DANONE: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 67.DANONE: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 68.NESTLE S.A.: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 69.NESTLE S.A.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 70.NESTLE S.A.: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 71.PROBI AB: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 72.PROBI AB: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 73.PROBI AB: REVENUE SHARE BY REGION, 2020 (%)
  • FIGURE 74.YAKULT HONSHA CO., LTD.: R&D EXPENDITURE, 2018-2020 ($MILLION)
  • FIGURE 75.YAKULT HONSHA CO., LTD.: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 76.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY SEGMENT, 2020 (%)
  • FIGURE 77.YAKULT HONSHA CO., LTD.: REVENUE SHARE BY REGION, 2020 (%)
目次
Product Code: A00192

The global probiotics market size was valued at $34.1 billion in 2020, and is projected to reach $73.9 billion by 2030, registering a CAGR of 8.6%

Probiotics are made up of good live bacteria and/or yeasts that exist naturally in the body. A body contains both good and bad bacteria. When a person gets an infection, more bad bacteria enter the body, throwing the body system out of whack. Good bacteria aids in the elimination of excessive bad bacteria, restoring balance. Probiotic supplements are a way to increase the number of good bacteria in the body.

Probiotics have beneficial effects on the human body when consumed in sufficient quantities, such as improved gut health and decreased intestinal inflammation. Probiotics play an important role in preventive healthcare as they strengthen the immune system, which prevents diseases from occurring. As a result, rise in awareness of preventive healthcare is expected to benefit overall market growth.

A healthy lifestyle and dietary choices that aid in disease prevention are examples of preventive healthcare. Preventive healthcare awareness has grown as a result of a variety of factors, including surge in disposable income, rise in living standards, and an increase in the number of the elderly. In addition, the ease of access to information about preventive healthcare on the internet has helped to raise awareness.

Regulations regarding the use of probiotics in nutraceuticals, nutraceutical cosmetics, and dietary supplements, particularly infant formulas, are extremely stringent in some regions and are expected to pose a challenge to market players.

The COVID-19 pandemic had a positive impact on probiotics market. Some of the probiotics products and ingredient are used to enhance immunity in the body. Many market players had invested large amount of money on the new versions of probiotics products.

The probiotics market is segmented on the basis of ingredient, function, application, end user, and region. On the basis of ingredient, the market is categorized intobacteria and yeast. On the basis of function, the probiotics market is segmented into regular, preventative healthcare, and therapeutic. As per application, it is divided into food & beverage, dietary supplement, and animal feed.

According to end user, the probiotics market is fragmented into human and animal. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, France, the Netherlands, Germany, Turkey, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, the UAE, and the rest of LAMEA).

As a result of global players' competitive strategies, Asia-Pacific has seen a significant increase in consumer awareness. Strong demand from countries such as India, China, and Australia has contributed to overall growth. The increase in population, combined with rise in disposable income and standard of living, is expected to contribute to overall growth.

The factors such as rapid growth in the food & beverage industry in developing countries, such as India and China, and rise inawareness of the benefits of probiotic food products drive the market.The major players operating in the global probiotics market are BioGaia AB, Danone, Chr. Hansen Holding A/S, Yakult Honsha Co. Ltd., Probi AB, Lifeway Foods, Inc., Nestle S.A., Ganeden, Inc., E. I. du Pont de Nemours and Company, and Protexin.

Key Benefits for Stakeholders

This report provides a quantitative analysis of current trends, estimations, and dynamics of the global probiotics market from 2021 to 2030 to identify the prevailing market opportunities.

Porter's five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global industry. The market player positioning segment facilitates benchmarking while providing a clear understanding of the present position of the key market players.

The report includes analysis of the regional as well as global market, key players, market segments, application areas, and growth strategies.

Key Market Segments

By Ingredient

  • Bacteria
  • Yeast

By Function

  • Regular
  • Preventative Healthcare
  • Therapeutic

By Application

  • Food & Beverage
  • Dietary Supplements
  • Animal Feed

By End User

  • Human
  • Animal

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • France
  • Netherlands
  • Germany
  • Turkey
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • UAE
  • Rest of LAMEA

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Primary research
    • 1.4.2.Secondary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Market share analysis/top player positioning, 2020
  • 3.5.Top impacting factors
    • 3.5.1.Growing health concerns
    • 3.5.2.Low awareness among consumers
    • 3.5.3.Increasing investment on R&D
    • 3.5.4.Stringent government regulations
    • 3.5.5.Rising consumption of functional foods
  • 3.6.Market dynamics
    • 3.6.1.Drivers
      • 3.6.1.1.Growing health concerns
      • 3.6.1.2.Rising consumption of functional foods
      • 3.6.1.3.Increasing investment in Research & Development
    • 3.6.2.Restraints
      • 3.6.2.1.Government regulations
      • 3.6.2.2.Low awareness level among consumers about effectiveness of probiotic products
    • 3.6.3.Opportunities
      • 3.6.3.1.Rising demand of probiotic products in developing nations
      • 3.6.3.2.Creating awareness about the benefits of probiotics
  • 3.7.Impact of COVID-19
  • 3.8.Value chain analysis
    • 3.8.1.Research and Development:
    • 3.8.2.Raw material supplier:
    • 3.8.3.Production:
    • 3.8.4.Commercialization:
    • 3.8.5.End Users:

CHAPTER 4:PROBIOTICS MARKET, BY INGREDIENTS

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Bacteria
    • 4.2.1.Overview
    • 4.2.2.Key market trends, growth factors, and opportunities
    • 4.2.3.Market size and forecast
  • 4.3.Yeast
    • 4.3.1.Overview
    • 4.3.2.Key market trends, growth factors, and opportunities
    • 4.3.3.Market size and forecast

CHAPTER 5:PROBIOTICS MARKET, BY FUNCTION

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Regular
    • 5.2.1.Overview
    • 5.2.2.Key market trends, growth factors, and opportunities
    • 5.2.3.Market size and forecast
  • 5.3.Preventative healthcare
    • 5.3.1.Overview
    • 5.3.2.Key market trends, growth factors, and opportunities
    • 5.3.3.Market size and forecast
  • 5.4.Therapeutic
    • 5.4.1.Overview
    • 5.4.2.Key market trends, growth factors, and opportunities
    • 5.4.3.Market size and forecast

CHAPTER 6:PROBIOTICS MARKET, BY APPLICATION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Food & beverage
    • 6.2.1.Overview
    • 6.2.2.Key market trends, growth factors, and opportunities
    • 6.2.3.Market size and forecast
  • 6.3.Dietary supplements
    • 6.3.1.Overview
    • 6.3.2.Key market trends, growth factors, and opportunities
    • 6.3.3.Market size and forecast
  • 6.4.Animal feed
    • 6.4.1.Overview
    • 6.4.2.Key market trends, growth factors, and opportunities
    • 6.4.3.Market size and forecast

CHAPTER 7:PROBIOTICS MARKET, BY END USER

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.Human
    • 7.2.1.Overview
    • 7.2.2.Key market trends, growth factors, and opportunities
    • 7.2.3.Market size and forecast
  • 7.3.Animal
    • 7.3.1.Overview
    • 7.3.2.Key market trends, growth factors, and opportunities
    • 7.3.3.Market size and forecast

CHAPTER 8:PROBIOTICS MARKET, BY REGION

  • 8.1.Overview
    • 8.1.1.Market size and forecast
  • 8.2.North America
    • 8.2.1.Overview
    • 8.2.2.Key market trends, growth factors, and opportunities
    • 8.2.3.Market size and forecast, by ingredients
    • 8.2.4.Market size and forecast, by function
    • 8.2.5.Market size and forecast, by application
    • 8.2.6.Market size and forecast, by end user
    • 8.2.7.Market size and forecast, by country
      • 8.2.7.1.U.S.
      • 8.2.7.1.1.Market size and forecast, by ingredients
      • 8.2.7.1.2.Market size and forecast, by function
      • 8.2.7.1.3.Market size and forecast, by application
      • 8.2.7.1.4.Market size and forecast, by end user
      • 8.2.7.2.Canada
      • 8.2.7.2.1.Market size and forecast, by ingredients
      • 8.2.7.2.2.Market size and forecast, by function
      • 8.2.7.2.3.Market size and forecast, by application
      • 8.2.7.2.4.Market size and forecast, by end user
      • 8.2.7.3.Mexico
      • 8.2.7.3.1.Market size and forecast, by ingredients
      • 8.2.7.3.2.Market size and forecast, by function
      • 8.2.7.3.3.Market size and forecast, by application
      • 8.2.7.3.4.Market size and forecast, by end user
  • 8.3.Europe
    • 8.3.1.Overview
    • 8.3.2.Key market trends, growth factors, and opportunities
    • 8.3.3.Market size and forecast, by ingredients
    • 8.3.4.Market size and forecast, by function
    • 8.3.5.Market size and forecast, by application
    • 8.3.6.Market size and forecast, by end user
    • 8.3.7.Market size and forecast, by country
      • 8.3.7.1.UK
      • 8.3.7.1.1.Market size and forecast, by ingredients
      • 8.3.7.1.2.Market size and forecast, by function
      • 8.3.7.1.3.Market size and forecast, by application
      • 8.3.7.1.4.Market size and forecast, by end user
      • 8.3.7.2.France
      • 8.3.7.2.1.Market size and forecast, by ingredients
      • 8.3.7.2.2.Market size and forecast, by function
      • 8.3.7.2.3.Market size and forecast, by application
      • 8.3.7.2.4.Market size and forecast, by end user
      • 8.3.7.3.The Netherlands
      • 8.3.7.3.1.Market size and forecast, by ingredients
      • 8.3.7.3.2.Market size and forecast, by function
      • 8.3.7.3.3.Market size and forecast, by application
      • 8.3.7.3.4.Market size and forecast, by end user
      • 8.3.7.4.Germany
      • 8.3.7.4.1.Market size and forecast, by ingredients
      • 8.3.7.4.2.Market size and forecast, by function
      • 8.3.7.4.3.Market size and forecast, by application
      • 8.3.7.4.4.Market size and forecast, by end user
      • 8.3.7.5.Turkey
      • 8.3.7.5.1.Market size and forecast, by ingredients
      • 8.3.7.5.2.Market size and forecast, by function
      • 8.3.7.5.3.Market size and forecast, by application
      • 8.3.7.5.4.Market size and forecast, by end user
      • 8.3.7.6.Rest of Europe
      • 8.3.7.6.1.Market size and forecast, by ingredients
      • 8.3.7.6.2.Market size and forecast, by function
      • 8.3.7.6.3.Market size and forecast, by application
      • 8.3.7.6.4.Market size and forecast, by end user
  • 8.4.Asia-Pacific
    • 8.4.1.Overview
    • 8.4.2.Key market trends, growth factors, and opportunities
    • 8.4.3.Market size and forecast, by ingredients
    • 8.4.4.Market size and forecast, by function
    • 8.4.5.Market size and forecast, by application
    • 8.4.6.Market size and forecast, by end user
    • 8.4.7.Market size and forecast, by country
      • 8.4.7.1.China
      • 8.4.7.1.1.Market size and forecast, by ingredients
      • 8.4.7.1.2.Market size and forecast, by function
      • 8.4.7.1.3.Market size and forecast, by application
      • 8.4.7.1.4.Market size and forecast, by end user
      • 8.4.7.2.Japan
      • 8.4.7.2.1.Market size and forecast, by ingredients
      • 8.4.7.2.2.Market size and forecast, by function
      • 8.4.7.2.3.Market size and forecast, by application
      • 8.4.7.2.4.Market size and forecast, by end user
      • 8.4.7.3.India
      • 8.4.7.3.1.Market size and forecast, by ingredients
      • 8.4.7.3.2.Market size and forecast, by function
      • 8.4.7.3.3.Market size and forecast, by application
      • 8.4.7.3.4.Market size and forecast, by end user
      • 8.4.7.4.South Korea
      • 8.4.7.4.1.Market size and forecast, by ingredients
      • 8.4.7.4.2.Market size and forecast, by function
      • 8.4.7.4.3.Market size and forecast, by application
      • 8.4.7.4.4.Market size and forecast, by end user
      • 8.4.7.5.Australia
      • 8.4.7.5.1.Market size and forecast, by ingredients
      • 8.4.7.5.2.Market size and forecast, by function
      • 8.4.7.5.3.Market size and forecast, by application
      • 8.4.7.5.4.Market size and forecast, by end user
      • 8.4.7.6.Rest of Asia-Pacific
      • 8.4.7.6.1.Market size and forecast, by ingredients
      • 8.4.7.6.2.Market size and forecast, by function
      • 8.4.7.6.3.Market size and forecast, by application
      • 8.4.7.6.4.Market size and forecast, by end user
  • 8.5.LAMEA
    • 8.5.1.Overview
    • 8.5.2.Key market trends, growth factors, and opportunities
    • 8.5.3.Market size and forecast, by ingredients
    • 8.5.4.Market size and forecast, by function
    • 8.5.5.Market size and forecast, by application
    • 8.5.6.Market size and forecast, by end user
    • 8.5.7.Market size and forecast, by country
      • 8.5.7.1.Brazil
      • 8.5.7.1.1.Market size and forecast, by ingredients
      • 8.5.7.1.2.Market size and forecast, by function
      • 8.5.7.1.3.Market size and forecast, by application
      • 8.5.7.1.4.Market size and forecast, by end user
      • 8.5.7.2.South Africa
      • 8.5.7.2.1.Market size and forecast, by ingredients
      • 8.5.7.2.2.Market size and forecast, by function
      • 8.5.7.2.3.Market size and forecast, by application
      • 8.5.7.2.4.Market size and forecast, by end user
      • 8.5.7.3.United Arab Emirates
      • 8.5.7.3.1.Market size and forecast, by ingredients
      • 8.5.7.3.2.Market size and forecast, by function
      • 8.5.7.3.3.Market size and forecast, by application
      • 8.5.7.3.4.Market size and forecast, by end user
      • 8.5.7.4.Rest of LAMEA
      • 8.5.7.4.1.Market size and forecast, by ingredients
      • 8.5.7.4.2.Market size and forecast, by function
      • 8.5.7.4.3.Market size and forecast, by application
      • 8.5.7.4.4.Market size and forecast, by end user

CHAPTER 9:COMPETITION LANDSCAPE

  • 9.1.Top winning strategies
  • 9.2.Product mapping
  • 9.3.Competitive dashboard
  • 9.4.Competitive heat map
  • 9.5.Key developments
    • 9.5.1.Acquisition
    • 9.5.2.Business Expansion
    • 9.5.3.Product Launch

CHAPTER 10:COMPANY PROFILES

  • 10.1.Archer-Daniels-Midland Company
    • 10.1.1.Company overview
    • 10.1.2.Key Executives
    • 10.1.3.Company snapshot
    • 10.1.4.Operating business segments
    • 10.1.5.Product portfolio
    • 10.1.6.R&D Expenditure
    • 10.1.7.Business performance
    • 10.1.8.Key strategic moves and developments
  • 10.2.BioGaia AB
    • 10.2.1.Company overview
    • 10.2.2.Key Executives
    • 10.2.3.Company snapshot
    • 10.2.4.Operating business segments
    • 10.2.5.Product portfolio
    • 10.2.6.R&D Expenditure
    • 10.2.7.Business performance
    • 10.2.8.Key strategic moves and developments
  • 10.3.Chr. Hansen Holding A/S
    • 10.3.1.Company overview
    • 10.3.2.Key Executives
    • 10.3.3.Company snapshot
    • 10.3.4.Operating business segments
    • 10.3.5.Product portfolio
    • 10.3.6.R&D Expenditure
    • 10.3.7.Business performance
    • 10.3.8.Key strategic moves and developments
  • 10.4.Danone
    • 10.4.1.Company overview
    • 10.4.2.Key Executives
    • 10.4.3.Company snapshot
    • 10.4.4.Product portfolio
    • 10.4.5.Business performance
  • 10.5.Deerland Probiotics & Enzymes Inc.
    • 10.5.1.Company overview
    • 10.5.2.Key Executives
    • 10.5.3.Company snapshot
    • 10.5.4.Product portfolio
    • 10.5.5.Key strategic moves and developments
  • 10.6.Lallemand Inc.
    • 10.6.1.Company overview
    • 10.6.2.Key Executives
    • 10.6.3.Company snapshot
    • 10.6.4.Product portfolio
    • 10.6.5.Key strategic moves and developments
  • 10.7.Nestle S.A
    • 10.7.1.Company overview
    • 10.7.2.Key Executives
    • 10.7.3.Company snapshot
    • 10.7.4.Operating business segments
    • 10.7.5.Product portfolio
    • 10.7.6.R&D Expenditure
    • 10.7.7.Business performance
    • 10.7.8.Key strategic moves and developments
  • 10.8.Probi AB
    • 10.8.1.Company overview
    • 10.8.2.Key Executives
    • 10.8.3.Company snapshot
    • 10.8.4.Operating business segments
    • 10.8.5.Product portfolio
    • 10.8.6.R&D Expenditure
    • 10.8.7.Business performance
    • 10.8.8.Key strategic moves and developments
  • 10.9.Probiotical S.P.A.
    • 10.9.1.Company overview
    • 10.9.2.Key Executives
    • 10.9.3.Company snapshot
    • 10.9.4.Product portfolio
  • 10.10.Yakult Honsha Co. Ltd
    • 10.10.1.Company overview
    • 10.10.2.Key Executives
    • 10.10.3.Company snapshot
    • 10.10.4.Operating business segments
    • 10.10.5.Product portfolio
    • 10.10.6.R&D Expenditure
    • 10.10.7.Business performance
    • 10.10.8.Key strategic moves and developments